Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and ...
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and ... Tonix Pharmaceuticals Holding Corp.March 15, 2021 GMT Announced Positive Phase 3 RELIEF Study Results for TNX-102 SL 5.6 mg in Fibromyalgia Interim Analysis Results from Second Confirmatory Phase 3 Study, RALLY, Expected in Third Quarter 2021: Interim Cohort Enrolled Efficacy Data from Animal Studies of COVID-19 Vaccine Candidate, TNX-1800, Expected in First Quarter 2021 Phase 1 Safety Study in Humans of TNX-18...
Source: apnews.com